- Forums
- ASX - By Stock
- ZLD
- Ann: Zeliras diabetic nerve pain drug outperforms Lyrica
Ann: Zeliras diabetic nerve pain drug outperforms Lyrica, page-41
-
-
- There are more pages in this discussion • 177 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ZLD (ASX) to my watchlist
|
|||||
Last
$1.08 |
Change
0.280(35.0%) |
Mkt cap ! $11.34M |
Open | High | Low | Value | Volume |
81.5¢ | $1.09 | 81.5¢ | $31.36K | 31.84K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7943 | $1.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.09 | 9786 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8343 | 1.080 |
1 | 657 | 1.000 |
1 | 297 | 0.990 |
1 | 2000 | 0.950 |
1 | 5000 | 0.900 |
Price($) | Vol. | No. |
---|---|---|
1.090 | 10286 | 2 |
1.140 | 2500 | 1 |
1.145 | 834 | 2 |
1.150 | 6000 | 1 |
1.160 | 6000 | 1 |
Last trade - 12.16pm 16/07/2024 (20 minute delay) ? |
Featured News
ZLD (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, CEO / Non-Exec Director
James Graham / Dr Alan Dunton
CEO / Non-Exec Director
SPONSORED BY The Market Online